143 related articles for article (PubMed ID: 33128104)
1. Neuropsychiatric symptoms and striatal monoamine availability in early Parkinson's disease without dementia.
Oh YS; Kim JH; Yoo SW; Hwang EJ; Lyoo CH; Lee KS; Kim JS
Neurol Sci; 2021 Feb; 42(2):711-718. PubMed ID: 33128104
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine activity and myocardial
Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
Parkinsonism Relat Disord; 2019 Jun; 63():156-161. PubMed ID: 30796009
[TBL] [Abstract][Full Text] [Related]
3. Low thalamic monoamine transporter availability is related to excessive daytime sleepiness in early Parkinson's disease.
Yoo SW; Oh YS; Ryu DW; Lee KS; Lyoo CH; Kim JS
Neurol Sci; 2020 May; 41(5):1081-1087. PubMed ID: 31872354
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.
Oh YS; Kim JS; Hwang EJ; Lyoo CH
Parkinsonism Relat Disord; 2018 Nov; 56():47-51. PubMed ID: 29925486
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
Oh Y; Kim JS; Lyoo CH; Park G; Kim H
Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
[TBL] [Abstract][Full Text] [Related]
6. Decreased thalamic monoamine availability in drug-induced parkinsonism.
Oh YS; Yoo SW; Lyoo CH; Kim JS
Sci Rep; 2022 Mar; 12(1):3749. PubMed ID: 35260679
[TBL] [Abstract][Full Text] [Related]
7. "Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.
Yoo SW; Oh YS; Hwang EJ; Ryu DW; Lee KS; Lyoo CH; Kim JS
Neurobiol Dis; 2019 Dec; 132():104563. PubMed ID: 31377233
[TBL] [Abstract][Full Text] [Related]
8. Obstructive Sleep Apnea and Striatal Dopamine Availability in Parkinson's Disease.
Oh YS; Kim JS; Lyoo CH; Kim H
Mov Disord; 2023 Jun; 38(6):1068-1076. PubMed ID: 37046390
[TBL] [Abstract][Full Text] [Related]
9. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in the effect of uric acid on striatal dopamine in early Parkinson's disease.
Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
Eur J Neurol; 2020 Feb; 27(2):258-264. PubMed ID: 31446637
[TBL] [Abstract][Full Text] [Related]
11. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
Jeong SH; Lee HS; Jung JH; Baik K; Lee YH; Yoo HS; Sohn YH; Chung SJ; Lee PH
Mov Disord; 2021 Jun; 36(6):1411-1419. PubMed ID: 33513293
[TBL] [Abstract][Full Text] [Related]
12. Premorbid cancer and motor reserve in patients with Parkinson's disease.
Oh YS; Yoo SW; Lyoo CH; Lee KS; Kim JS
Sci Rep; 2022 Jun; 12(1):9254. PubMed ID: 35660777
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson Disease: An Early Phase
Chun MY; Chung SJ; Kim SH; Park CW; Jeong SH; Lee HS; Lee PH; Sohn YH; Jeong Y; Kim YJ
Ann Neurol; 2024 Feb; 95(2):388-399. PubMed ID: 37962393
[TBL] [Abstract][Full Text] [Related]
14. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
15. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
[TBL] [Abstract][Full Text] [Related]
17. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
[TBL] [Abstract][Full Text] [Related]
18. [
Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO
Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
